PW MEDTECH (01358) spent HKD 640,900 to repurchase 436,000 shares on October 24th.
PwC Consulting (01358) announced that on October 24, 2025, the company invested HKD 640,900...
PW MEDTECH (01358) announced on October 24, 2025, that the company will repurchase 436,000 shares at a cost of HK$640,900, with a repurchase price of HK$1.47 per share.
Related Articles
CNBM(03323): Beijing New Building Materials Public(000786.SZ) recorded a net profit attributable to the parent company of 2.586 billion RMB in the first three quarters, a year-on-year decrease of 17.77%.
Rizhao Port JR (06117) acquired 44 million H shares held by its controlling shareholder, Rizhao Port Co., Ltd.
China Shenhua Energy (01088) had a net profit attributable to the parent company of 41.366 billion yuan in the first three quarters, a year-on-year decrease of 13.8%.
CNBM(03323): Beijing New Building Materials Public(000786.SZ) recorded a net profit attributable to the parent company of 2.586 billion RMB in the first three quarters, a year-on-year decrease of 17.77%.
Rizhao Port JR (06117) acquired 44 million H shares held by its controlling shareholder, Rizhao Port Co., Ltd.
China Shenhua Energy (01088) had a net profit attributable to the parent company of 41.366 billion yuan in the first three quarters, a year-on-year decrease of 13.8%.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
